DBV Technologies (DBVT) Non-Current Assets (2014 - 2026)
DBV Technologies (DBVT) reported Non-Current Assets of $19.7 million for Q1 2026, down 8.0% year-over-year from $21.4 million in Q1 2025, and down 5.29% on a QoQ basis from $20.8 million in Q4 2025.
DBV Technologies (DBVT) has 13 years of Non-Current Assets data on file, last reported at $19.7 million in Q1 2026.
- Quarterly Non-Current Assets fell 8.0% year-over-year to $19.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.7 million (down 8.0% YoY) and the FY2025 annual result came in at $20.8 million, down 2.21% from the prior year.
- Non-Current Assets declined to $19.7 million in Q1 2026 per DBVT's latest filing, from $20.8 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $27.1 million in Q1 2022 and bottomed at $19.7 million in Q1 2026.
- The 5-year median for Non-Current Assets is $22.4 million (2022), against an average of $22.9 million.
- The widest annual swing landed in 2022, when Non-Current Assets plunged 63.11%; it then grew 18.44% in 2024.
- Tracing DBVT's Non-Current Assets over 5 years: stood at $23.4 million in 2022, then increased by 2.67% to $24.1 million in 2023, then slipped by 11.63% to $21.3 million in 2024, then fell by 2.21% to $20.8 million in 2025, then retreated by 5.29% to $19.7 million in 2026.
- Per Business Quant, the three latest DBVT Non-Current Assets figures stand at $19.7 million (Q1 2026), $20.8 million (Q4 2025), and $21.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 19.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.70 Mn |
| Dec 31, 2025 | 20.80 Mn |
| Sep 30, 2025 | 21.61 Mn |
| Jun 30, 2025 | 22.19 Mn |
| Mar 31, 2025 | 21.41 Mn |
| Dec 31, 2024 | 21.27 Mn |
| Sep 30, 2024 | 24.30 Mn |
| Jun 30, 2024 | 24.23 Mn |
| Mar 31, 2024 | 26.33 Mn |
| Dec 31, 2023 | 24.07 Mn |
| Sep 30, 2023 | 20.51 Mn |
| Jun 30, 2023 | 21.98 Mn |
| Mar 31, 2023 | 22.69 Mn |
| Dec 31, 2022 | 23.44 Mn |
| Sep 30, 2022 | 22.42 Mn |
| Jun 30, 2022 | 25.03 Mn |
| Mar 31, 2022 | 27.14 Mn |
| Dec 31, 2021 | 32.34 Mn |
| Sep 30, 2021 | 60.79 Mn |
| Jun 30, 2021 | 61.99 Mn |
| Mar 31, 2021 | 61.60 Mn |
| Dec 31, 2020 | 64.87 Mn |
| Jun 30, 2020 | 67.97 Mn |
| Dec 31, 2019 | 65.74 Mn |
| Sep 30, 2019 | 64.33 Mn |
| Jun 30, 2019 | 55.21 Mn |
| Dec 31, 2018 | 30.00 Mn |
| Jun 30, 2018 | 23.86 Mn |
| Dec 31, 2017 | 24.66 Mn |
| Jun 30, 2017 | 20.39 Mn |
| Dec 31, 2016 | 16.54 Mn |
| Jun 30, 2016 | 14.99 Mn |
| Dec 31, 2015 | 9.19 Mn |
| Jun 30, 2015 | 4.79 Mn |
| Dec 31, 2014 | 4.81 Mn |